Public Trading on Alvotech Shares Begins Globally - The Center for Biosimilars

Iceland-based Alvotech announced that the pureplay biosimilars company is debuting on the public market starting June 16.

Alvotech, a global pureplay biosimilars developer and manufacturer based in Reykjavik, Iceland, announced that public trading of its ordinary shares and warrants on the Nasdaq stock market starting J… [+2683 chars]

full article...